Pharmac is funding new medicine for people with ADHD and narcolepsy, and removing the renewal criteria for funded treatments.
Pharmac has announced it'll fund new stimulant medicine lisdexamfetamine from December. The medicine -- branded as Vyvanse -- is taken once a day. Chief medical officer, David Hughes, says it's a ...
Pharmac is funding new medicine for people with attention deficit hyperactivity disorder (ADHD) and narcolepsy, and removing ...
From 1 December 2024, Pharmac is also removing the renewal criteria for methylphenidate, dexamfetamine and modafinil, medicines used to treat ADHD and narcolepsy. This means that once an initial ...
Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.
Circle to Search is coming to compatible phones with OxygenOS 15 The update also adds new boot animation, icons, and shelf card choices OxygenOS 15 introduces Gemini-powered AI Notes ...
A council plans on battling “the plague” of shopping trolleys dumped in its rivers and streets by hitting supermarkets harder in the pocket. A wildlife reserve visitor centre has been damaged ...
Amphetamine- and methylphenidate-based drugs are the first-choice medications used for treating many people with attention deficit hyperactivity disorder (ADHD). They are available in a generic ...
A screenshot of the ABC News-hosted presidential debate between Kamala Harris and Donald Trump in September 2024. Picture: Youtube screenshot of Wall Street Journal debate stream Half of the world ...
A British dad has opened up on his experience after being prescribed medicinal cannabis to help him cope with his ADHD. Attention deficit hyperactivity disorder, or ADHD, is a condition that ...
In September 2024, the US Drug Enforcement Agency (DEA) announced it would permit the ramping up of the production of slow-release lisdexamfetamine dimestylate – best known by its brand name ...
This changed in the 1990s after the introduction of dexamphetamine, along with the subsequent availability of Vyvance (lisdexamfetamine). Perhaps the most significant change has come with 'slow ...